biocon-anti-psoriasis-drug - Latest News on biocon-anti-psoriasis-drug | Read Breaking News on Zee News

Biocon gets DCGI approval to market anti-psoriasis drug

Last Updated: Tuesday, January 08, 2013, 14:59

Biotechnology major Biocon on Tuesday said it has received approval from drug controller DCGI to market its product 'Itolizumab', used in the treatment of psoriasis.